Colomier, Esther
Melchior, Chloé
Algera, Joost P.
Hreinsson, Jóhann P.
Störsrud, Stine
Törnblom, Hans
Van Oudenhove, Lukas
Palsson, Olafur S.
Bangdiwala, Shrikant I.
Sperber, Ami D.
Tack, Jan
Simrén, Magnus
Funding for this research was provided by:
Swedish Research Counsil (2018-02566)
ALF-agreement (ALFGBG-722331, ALFGBG-726561)
Article History
Received: 8 October 2021
Accepted: 13 January 2022
First Online: 17 February 2022
Declarations
:
: All participants provided electronic consent before completing the study survey. The study was reviewed and deemed exempt from IRB human subjects oversight due to the anonymity of the survey method, by the Biomedical Institutional Review Board of the University of North Carolina at Chapel Hill (UNC IRB application number: 16-2486), the institution that served as Data Coordination Center and collected the survey data electronically from subjects in all the countries surveyed.
: Not applicable.
: C.M. has served as a consultant/advisory board member for Kyowa Kirin, Norgine, Biocodex, MayolySpindler, Tillots, and Ipsen. S.S. has served as an advisory board member for Takeda and speaker for Viatris. H.T. has served as an advisory board member/consultant for Almirall and Shire. L.V.O. is assistant research professor of the KU Leuven Special Research Fund (Bijzonder Onderzoeksfonds, BOF). A.D.S. has served as a consultant for Lapidot Israel and AbbVie-Israel outside the submitted work. O.S.P. has received a research contract from the Rome Foundation during the conduct of the study and received a research contract from Glycom A/S and Royal DSM and personal fees from metaMe Health, outside the submitted work. J.T. has given scientific advice to Adare, AlfaWassermann, Allergan, Arena, Bayer, Christian Hansen, Clasado, Danone, Devintec, Falk, Grünenthal, Ironwood, Janssen, Kiowa Kirin, Menarini, Mylan, Neurogastrx, Neutec, Novartis, Noventure, Nutricia, Shionogi, Shire, Takeda, Theravance, Tramedico, Truvion, Tsumura, Zealand, and Zeria Pharmaceutical; received research support from Shire, Sofar, and Tsumura; and served on the Speakers Bureau for Abbott, Allergan, AstraZeneca, Janssen, Kyowa Kirin, Menarini, Mylan, Novartis, Shire, Takeda, Truvion, and Zeria Pharmaceutical, all outside the submitted work. M.S. has received grants and personal fees from Gkycom and Danone Nutricia Research; personal fees from Ironwood, Menarini, Biocodex, Adnovate, Arena, Tillotts, Kyowa Kirin, Takeda, Alimentary Health, AlfaSigma, and the Falk Foundation; and grants from Genetic Analysis AS, outside the submitted work. The remaining authors disclose no conflicts.